Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID study

Jan-Paul Roozeman(Amsterdam University Medical Centers), C.K. Algoe, Janneke Horn(Amsterdam UMC Location University of Amsterdam), Frederique Paulus(Amsterdam University Medical Centers), Margriet Bogerd(Amsterdam University Medical Centers), A.E. van den Berg, Marcus J. Schultz(University of St.Gallen), Luigi Pisani(Ospedale Generale Regionale Francesco Miulli), Rombout B. E. van Amstel, Antonio Artigas(University of Milan), Anna Geke Algera, J.P. van Akkeren, Alexander J. G. H. Bindels(University Medical Center Utrecht), Ary Serpa Neto(The University of Melbourne), Lieuwe D. J. Bos(Amsterdam Neuroscience), Jennifer S. Breel, L.S. Boers(Amsterdam UMC Location University of Amsterdam), Michela Botta(Amsterdam University Medical Centers), M.M. de Boer, Markus W. Hollmann(European Society of Anaesthesiology), Alexander P. J. Vlaar(Amsterdam Neuroscience), Guido Mazzinari(Hospital Universitari i Politècnic La Fe), Dave A. Dongelmans(Amsterdam UMC Location University of Amsterdam), Janesh Pillay(University Medical Center Groningen), Laura A. Buiteman‐Kruizinga, O Baur, C.L. Bruna, Sanne de Bruin(Amsterdam University Medical Centers), F.A. Bertens, Olaf L. Cremer(University Medical Center Utrecht), Sanchit Ahuja(Cleveland Clinic), Anissa M. Tsonas(Amsterdam UMC Location University of Amsterdam), Willem Dieperink, R.M. Determann, H. de Bruin, D. C. J. J. Bergmans, Sylvia den Boer, D.I. van den Bersselaar, P. van de Berg
Journal of Critical Care
December 3, 2021
Cited by 22


Related Papers